Syngoi Technologies will be attending the European summit specializing in the mRNA processing and manufacturing market.
September 25, 2023. Boston.
From September 26th to 28th, the 2nd mRNA Process Development & Manufacturing Summit will take place in Boston, where Syngoi Technologies will also be a sponsor. This summit serves as the most comprehensive and technical industry-specific forum dedicated to addressing key challenges in the industry, such as securing quality starting materials, implementing quality by design, and automating large-scale manufacturing. The ultimate goal is to reduce mRNA production costs while aligning with regulatory expectations.
Julen Oyarzabal, CSO & Founder of Syngoi Technologies, will be participating as an Expert Speaker at the Leading Solution Partners event on Tuesday, September 26th, at 11:30 AM. During his session, Julen Oyarzabal will discuss “Optimized Linear Synthetic DNA as GMP Starting Material to Improve mRNA Production & Delivery Times.” This presentation will cover various topics, including enhancing in vitro transcription (IVT) yield to reduce the cost per dosage, the rapid development of more accurate and optimized linear DNA templates for advanced therapies, and the delivery of safer starting materials containing only the sequence of interest, free from any bacterial DNA.
Furthermore, on Wednesday, September 27th, at 3:30 PM, we invite you to join a tech slam featuring SYNGOI, offering you the chance to engage with our team.
You can download the program here.
